PC CTP 2016

Dr Verzoni (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy) chairs this discussion with Prof Maroto-Rey (Hospital de la Santa Creu i Sant Pau, Barcelona, Spain), Dr Senkus-Konefka (Medical University of Gdansk, Gdansk, Poland), and Dr Simon Crabb (University of Southampton, Southampton, UK) for ecancertv about the latest prostate cancer treatments and strategies. In particular, they discuss management strategies for the treatment of hormone sensitive patients and how the appropriate selection of patients for chemotherapy. There is an acknowledgement and agreement about the current challenges of managing castration resistant disease without sufficient level 1 evidence from reported trials. They also share their highlights from the meeting debates, regarding the various sequencing options for patients given either hormone therapy or chemotherapy as 1L treatment options. The panel look to the future and highlight the future PARP and immunotherapy trials, and state the need for additional diagnostics within prostate cancer to truly personalise therapeutic options.